Yoga has been found to assist in the quick recovery of individuals experiencing opioid withdrawal, while also improving their anxiety, sleep, and pain levels, as per a study. Opioid withdrawal is characterized by various physical symptoms like diarrhea, insomnia, fever, pain, anxiety, and depression, along with autonomic signs such as pupil dilation, runny nose, goosebumps, anorexia, yawning, nausea, vomiting, and sweating, all stemming from overactivity in the sympathetic nervous system due to dysregulated noradrenergic outflow.
A study conducted by researchers from the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru and Harvard Medical School in the US advocates for the inclusion of yoga in withdrawal protocols as a neurobiologically informed intervention. The researchers highlighted that yoga can target fundamental regulatory processes beyond just managing symptoms.
Suddala Goutham, from the Department of Integrative Medicine at NIMHANS, stated, “In this trial, yoga significantly enhanced opioid withdrawal recovery through measurable autonomic and clinical improvements, supporting its integration into withdrawal protocols as a neurobiologically informed intervention.” Opioid use disorder (OUD), marked by recurrent opioid usage leading to significant physical, psychological, and social issues, poses a substantial global public health challenge.
In a randomized clinical trial involving 59 male participants with opioid use disorder, where some received yoga alongside standard buprenorphine treatment, those who practiced yoga achieved withdrawal stabilization 4.4 times faster than the control group. Additionally, they exhibited notable enhancements in heart rate variability, anxiety, sleep quality, and pain management.
The team emphasized, “In this randomized clinical trial, adjuvant yoga therapy significantly expedited opioid withdrawal recovery while addressing autonomic dysregulation. The simultaneous physiological, psychological, and symptomatic enhancements suggest that yoga may restore core regulatory processes beyond symptom management.” The findings were published in JAMA Psychiatry.
